サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427690

アルコール性肝炎治療の世界市場レポート 2024

Alcoholic Hepatitis Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アルコール性肝炎治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

アルコール性肝炎治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.9%の年間複合成長率（CAGR）で43億2,000万米ドルに成長すると予想されます。アルコール性肝炎治療薬の予測期間における成長は、新規治療薬の出現や有望な医薬品パイプライン、精密医療アプローチの採用、疾患病因の理解促進、肝臓の健康に対する関心の高まり、アルコール乱用に対処する公衆衛生政策の実施などの要因によって牽引されると予想されます。予測期間の主な動向には、個別化医療アプローチの採用、肝移植の動向、遠隔医療と遠隔監視の統合、共同調査の取り組み、革新的な医薬品ソリューションの開発が含まれます。

アルコール摂取に起因する肝疾患の有病率の拡大は、アルコール性肝炎治療市場の拡大を促進する重要な原動力となる見込みです。アルコール性肝疾患は、肝機能障害の結果として発症します。血液の解毒や消化を助ける胆汁の生成など、数多くの生理学的機能を担う肝臓は、アルコール摂取により損傷を受けます。アルコール性肝炎の治療は、罹患患者の肝臓炎症を標的とし、症状が重篤な患者の場合は病院での治療が必要になることがよくあります。たとえば、国立医学図書館が2021年12月に発表したデータによると、新型コロナウイルス感染症（COVID-19）のパンデミック中に1年間アルコール摂取が増加すると、さらに8,000人のアルコール関連肝疾患関連死亡、1万8,700人の肝不全、したがって、アルコール誘発性肝疾患の有病率の上昇は、アルコール性肝炎治療市場の成長を推進する重要な推進力として機能します。

個別化医療への注目の高まりにより、近い将来、アルコール性肝炎治療市場の拡大が促進されると予想されます。個別化医療とは、患者の遺伝子構造、環境、ライフスタイルにおける個人差を考慮した革新的な医療アプローチを指します。このアプローチにより、治療のカスタマイズ、感受性因子の特定、最適化された薬剤の選択、個別のリスク評価、副作用の軽減など、カスタマイズされた治療戦略が可能になります。治療計画を個人のニーズに合わせて調整することで、患者の関与とコンプライアンスを促進します。たとえば、STATが2022年10月に発表したレポートでは、75,000を超える遺伝子検査製品と300の個別化医薬品が利用可能であることが示されています。この個別化医療への注目の高まりは、アルコール性肝炎治療市場の成長を推進する重要な触媒となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のアルコール性肝炎治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 薬物治療
  • 幹細胞療法
  • 世界のアルコール性肝炎治療市場、薬剤クラス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • コルチコステロイド
  • 血液レオロジー剤
  • モノクローナル抗体
  • アナボリックステロイド
  • その他
  • 世界のアルコール性肝炎治療市場、投与経路別セグメンテーション：、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 注射
  • 世界のアルコール性肝炎治療市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 診療所
  • 民間治療センター

第7章 地域および国の分析

  • 世界のアルコール性肝炎治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のアルコール性肝炎治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • アルコール性肝炎治療市場の競合情勢
  • アルコール性肝炎治療市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson Services Inc.
    • F. Hoffmann-La Roche Ltd.
    • AbbVie Inc.
    • Novartis AG

第31章 その他の大手および革新的な企業

  • Sanofi PLC
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Torrent Pharmaceuticals Ltd.
  • Takeda Pharmaceutical Company Limited
  • Gilead Sciences Inc.
  • Merck KGaA
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca Plc
  • Cadila Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Mylan Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13534

Alcoholic hepatitis treatment involves interventions aimed at promoting abstinence from alcohol and addressing the symptoms of liver damage. The therapeutic approach to alcoholic hepatitis focuses on the cessation of alcohol consumption and the administration of medications to alleviate liver-related symptoms.

The primary modalities of treatment for alcoholic hepatitis include pharmaceutical interventions and stem cell therapy. Pharmaceutical treatment entails the use of medications, excluding food, to prevent, detect, treat, or alleviate the symptoms of diseases or abnormal conditions. Drug classes such as corticosteroids, hemorheologic agents, monoclonal antibodies, anabolic steroids, and others are administered through oral and injectable routes. These treatments are typically provided by healthcare facilities, clinics, and private treatment centers.

The alcoholic hepatitis treatment market research report is one of a series of new reports from The Business Research Company that provides alcoholic hepatitis treatment market statistics, including alcoholic hepatitis treatment industry global market size, regional shares, competitors with an alcoholic hepatitis treatment market share, detailed alcoholic hepatitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alcoholic hepatitis treatment industry. This alcoholic hepatitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alcoholic hepatitis treatment market size has grown strongly in recent years. It will grow from $2.95 billion in 2023 to $3.18 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth observed in the historic period for alcoholic hepatitis treatment can be attributed to factors such as a high prevalence of alcohol abuse, increased awareness and diagnostics, government initiatives addressing alcoholism, a rise in healthcare expenditure, and the impact of public health campaigns.

The alcoholic hepatitis treatment market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period for alcoholic hepatitis treatment is expected to be driven by factors such as the emergence of novel therapies and a promising drug pipeline, the adoption of precision medicine approaches, an enhanced understanding of disease pathogenesis, a rising focus on liver health, and the implementation of public health policies addressing alcohol abuse. Major trends in the forecast period include the adoption of personalized medicine approaches, trends in liver transplantation, the integration of telemedicine and remote monitoring, collaborative research initiatives, and the development of innovative drug solutions.

The escalating prevalence of liver diseases stemming from alcohol consumption is poised to be a significant driver fueling the expansion of the market for alcoholic hepatitis treatment. Alcoholic liver disease manifests as a result of impaired liver function. The liver, responsible for numerous physiological functions such as blood detoxification and bile production aiding digestion, experiences damage due to alcohol consumption. Treatment for alcoholic hepatitis targets liver inflammation in affected patients, often necessitating therapy in a hospital setting for those with severe manifestations of the condition. For instance, data from the National Library of Medicine in December 2021 predicted that an increase in alcohol use of one year during the COVID-19 pandemic could lead to 8,000 additional alcohol-related liver disease-related deaths, 18,700 cases of liver failure, and 1,000 instances of liver cancer by 2040. Hence, the heightened prevalence of alcohol-induced liver diseases acts as a significant impetus propelling the alcoholic hepatitis treatment market's growth.

The burgeoning emphasis on personalized medicine is anticipated to drive the expansion of the alcoholic hepatitis treatment market in the foreseeable future. Personalized medicine denotes an innovative medical approach that considers individual variations in patients' genetic makeup, environments, and lifestyles. This approach enables tailored treatment strategies, encompassing the customization of therapies, identification of susceptibility factors, optimized medication selection, individualized risk evaluation, and mitigation of adverse effects. It fosters patient engagement and compliance by aligning treatment plans with individual needs. For example, reports published by STAT in October 2022 indicated the availability of over 75,000 genetic testing products and 300 personalized medicines. This surging focus on personalized medicine stands as a significant catalyst propelling the growth of the alcoholic hepatitis treatment market.

Product innovation stands as a prominent and increasingly adopted trend within the alcoholic hepatitis treatment market. Companies engaged in this sector are placing significant emphasis on pioneering new products to maintain their competitive edge. An illustrative example is the July 2022 release by Roche Holding AG of the Elecsys HCV Duo, a groundbreaking dual antibody and antigen diagnostic test for hepatitis C virus (HCV). This innovative test enables independent and simultaneous detection of HCV antigen and antibody status using a single human plasma or serum sample. It aids in identifying patients in recovery or exhibiting chronic infection symptoms that might lead to conditions such as liver cancer or early-stage infections. The early manifestation of HCV's core antigen during infection, utilized as an indicator of ongoing viral replication, enables physicians to diagnose active HCV at an earlier stage compared to using solely antibody assays, enhancing diagnostic capabilities.

Prominent entities in the alcoholic hepatitis treatment market are channeling their efforts towards product development, specifically focusing on immunoassays, as a strategic driver for revenue generation. Immunoassays represent a type of biochemical testing method leveraging antibodies' specific binding to antigens to detect and quantify the presence or concentration of a target molecule (analyte) in a sample. For instance, in November 2023, F. Hoffmann-La Roche Ltd. unveiled Elecsys HBeAg quant, an immunoassay designed to measure hepatitis B e antigen (HBeAg) levels in human serum and plasma in both qualitative and quantitative formats. It serves as a predictive tool for chronic active hepatitis and an early indicator of acute hepatitis B infection. This test aids in diagnosing and monitoring individuals with hepatitis B virus infection when complemented with supplementary laboratory findings and clinical data. The Elecsys HBeAg quant, compatible with Roche's Cobas e analyzers, is intended for use with samples from patients with known positive results as well as those with an undetermined HBeAg status.

In October 2022, the France-based biotechnology company Genfit completed the acquisition of Versantis AG for an undisclosed amount. This strategic move enhances GENFIT's leadership position in acute-on-chronic liver failure (ACLF) and significantly broadens its pipeline. The acquisition brings valuable assets to GENFIT's portfolio, including VS-01-ACLF, a Phase 2-ready program based on first-in-class scavenging liposomes technology, VS-01-UCD, a pediatric program targeting urea cycle disorder (UCD), and VS-02-HE, an early-stage program focusing on hepatic encephalopathy (HE). Versantis AG, based in Switzerland, is a biotech company specializing in the development of therapeutics for hepatitis and alcohol-related liver diseases.

Major companies operating in the alcoholic hepatitis treatment market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Sanofi PLC, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Torrent Pharmaceuticals Ltd., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KGaA, Viatris Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Cadila Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Mylan Inc., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Alkermes PLC, Intercept Pharmaceuticals Inc., Apotex Inc., Durect Corp.

North America was the largest region in the alcoholic hepatitis treatment market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the alcoholic hepatitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alcoholic hepatitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alcoholic hepatitis treatment market consists of revenues earned by entities by providing infection surveillance, ulcer prophylaxis, and liver transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The alcoholic hepatitis treatment market also includes sales of anti-inflammatory medication such as steroids, pentoxifylline, and glucocorticoids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alcoholic Hepatitis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alcoholic hepatitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alcoholic hepatitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alcoholic hepatitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Treatment: Drug Treatment; Stem Cell Therapy
  • 2) By Drug Class: Corticosteroids; Hemorheologic Agents; Monoclonal Antibodies; Anabolic Steroids; Other Drug Classes
  • 3) By Route of Administration: Oral; Injectable
  • 4) By Application: Hospital; Clinic; Private Treatment Center
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Alcoholic Hepatitis Treatment Market Characteristics

3. Alcoholic Hepatitis Treatment Market Trends And Strategies

4. Alcoholic Hepatitis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Alcoholic Hepatitis Treatment Market Size and Growth

  • 5.1. Global Alcoholic Hepatitis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Alcoholic Hepatitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Alcoholic Hepatitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Alcoholic Hepatitis Treatment Market Segmentation

  • 6.1. Global Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Treatment
  • Stem Cell Therapy
  • 6.2. Global Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Corticosteroids
  • Hemorheologic Agents
  • Monoclonal Antibodies
  • Anabolic Steroids
  • Other Drug Classes
  • 6.3. Global Alcoholic Hepatitis Treatment Market, Segmentation By Route of Administration:, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectable
  • 6.4. Global Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Clinic
  • Private Treatment Center

7. Alcoholic Hepatitis Treatment Market Regional And Country Analysis

  • 7.1. Global Alcoholic Hepatitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Alcoholic Hepatitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Alcoholic Hepatitis Treatment Market

  • 8.1. Asia-Pacific Alcoholic Hepatitis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Alcoholic Hepatitis Treatment Market

  • 9.1. China Alcoholic Hepatitis Treatment Market Overview
  • 9.2. China Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Alcoholic Hepatitis Treatment Market

  • 10.1. India Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Alcoholic Hepatitis Treatment Market

  • 11.1. Japan Alcoholic Hepatitis Treatment Market Overview
  • 11.2. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Alcoholic Hepatitis Treatment Market

  • 12.1. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Alcoholic Hepatitis Treatment Market

  • 13.1. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Alcoholic Hepatitis Treatment Market

  • 14.1. South Korea Alcoholic Hepatitis Treatment Market Overview
  • 14.2. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Alcoholic Hepatitis Treatment Market

  • 15.1. Western Europe Alcoholic Hepatitis Treatment Market Overview
  • 15.2. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Alcoholic Hepatitis Treatment Market

  • 16.1. UK Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Alcoholic Hepatitis Treatment Market

  • 17.1. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Alcoholic Hepatitis Treatment Market

  • 18.1. France Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Alcoholic Hepatitis Treatment Market

  • 19.1. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Alcoholic Hepatitis Treatment Market

  • 20.13. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Alcoholic Hepatitis Treatment Market

  • 21.1. Eastern Europe Alcoholic Hepatitis Treatment Market Overview
  • 21.2. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Alcoholic Hepatitis Treatment Market

  • 22.1. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Alcoholic Hepatitis Treatment Market

  • 23.1. North America Alcoholic Hepatitis Treatment Market Overview
  • 23.2. North America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Alcoholic Hepatitis Treatment Market

  • 24.1. USA Alcoholic Hepatitis Treatment Market Overview
  • 24.2. USA Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Alcoholic Hepatitis Treatment Market

  • 25.1. Canada Alcoholic Hepatitis Treatment Market Overview
  • 25.2. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Alcoholic Hepatitis Treatment Market

  • 26.1. South America Alcoholic Hepatitis Treatment Market Overview
  • 26.2. South America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Alcoholic Hepatitis Treatment Market

  • 27.1. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Alcoholic Hepatitis Treatment Market

  • 28.1. Middle East Alcoholic Hepatitis Treatment Market Overview
  • 28.2. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Alcoholic Hepatitis Treatment Market

  • 29.1. Africa Alcoholic Hepatitis Treatment Market Overview
  • 29.2. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Alcoholic Hepatitis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Alcoholic Hepatitis Treatment Market Competitive Landscape
  • 30.2. Alcoholic Hepatitis Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Alcoholic Hepatitis Treatment Market Other Major And Innovative Companies

  • 31.1. Sanofi PLC
  • 31.2. Bristol-Myers Squibb Company
  • 31.3. GlaxoSmithKline Plc
  • 31.4. Torrent Pharmaceuticals Ltd.
  • 31.5. Takeda Pharmaceutical Company Limited
  • 31.6. Gilead Sciences Inc.
  • 31.7. Merck KGaA
  • 31.8. Viatris Inc.
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. AstraZeneca Plc
  • 31.11. Cadila Pharmaceuticals
  • 31.12. Sun Pharmaceutical Industries Ltd.
  • 31.13. Mylan Inc.
  • 31.14. Dr. Reddy's Laboratories Ltd.
  • 31.15. Cipla Ltd.

32. Global Alcoholic Hepatitis Treatment Market Competitive Benchmarking

33. Global Alcoholic Hepatitis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Alcoholic Hepatitis Treatment Market

35. Alcoholic Hepatitis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Alcoholic Hepatitis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Alcoholic Hepatitis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Alcoholic Hepatitis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer